Cargando…
The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products
The majority of adults in the U.S. now have state-legal access to medical or recreational cannabis products, despite their federal prohibition. Given the wide array of pharmacologically active compounds in these products, it is essential that their biochemical profile is measured and reported to con...
Autores principales: | Jikomes, Nick, Zoorob, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5852027/ https://www.ncbi.nlm.nih.gov/pubmed/29540728 http://dx.doi.org/10.1038/s41598-018-22755-2 |
Ejemplares similares
-
Author Correction: The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products
por: Jikomes, Nick, et al.
Publicado: (2020) -
The frequency distribution of reported THC concentrations of legal cannabis flower products increases discontinuously around the 20% THC threshold in Nevada and Washington state
por: Zoorob, Michael J.
Publicado: (2021) -
On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices
por: Tassone, Felicia, et al.
Publicado: (2023) -
The phytochemical diversity of commercial Cannabis in the United States
por: Smith, Christiana J., et al.
Publicado: (2022) -
The legalization of cannabinoid products and standardizing cannabis-drug development
in the United States: a brief report
por: Marcu, Jahan
Publicado: (2020)